India’s Sun Pharma Reported Bid For Bausch & Lomb And Meda Raises Hopes For Bigger Buyouts
This article was originally published in PharmAsia News
Executive Summary
Sun Pharma has been increasingly linked to a potential global deal in the branded and specialty segments. With former Teva CEO Israel Makov as Sun’s chairman, and robust earnings continuing to pour in, a deal may be just around the corner.